- Home
- BETR vs QTRX Comparison
BETR vs QTRX Comparison
Compare BETR & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BETR
- QTRX
- Stock Information
- Founded
- BETR 2014
- QTRX 2007
- Country
- BETR United States
- QTRX United States
- Employees
- BETR N/A
- QTRX N/A
- Industry
- BETR Finance: Consumer Services
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- BETR Finance
- QTRX Industrials
- Exchange
- BETR Nasdaq
- QTRX Nasdaq
- Market Cap
- BETR 203.4M
- QTRX 241.2M
- IPO Year
- BETR N/A
- QTRX 2017
- Fundamental
- Price
- BETR $79.52
- QTRX $6.06
- Analyst Decision
- BETR
- QTRX Hold
- Analyst Count
- BETR 0
- QTRX 4
- Target Price
- BETR N/A
- QTRX $11.75
- AVG Volume (30 Days)
- BETR 1.9M
- QTRX 417.8K
- Earning Date
- BETR 11-12-2025
- QTRX 11-11-2025
- Dividend Yield
- BETR N/A
- QTRX N/A
- EPS Growth
- BETR N/A
- QTRX N/A
- EPS
- BETR N/A
- QTRX N/A
- Revenue
- BETR $130,672,000.00
- QTRX $125,784,000.00
- Revenue This Year
- BETR $55.38
- QTRX N/A
- Revenue Next Year
- BETR $71.18
- QTRX $37.89
- P/E Ratio
- BETR N/A
- QTRX N/A
- Revenue Growth
- BETR 69.42
- QTRX N/A
- 52 Week Low
- BETR $7.71
- QTRX $4.05
- 52 Week High
- BETR $94.06
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- BETR 70.58
- QTRX 61.51
- Support Level
- BETR $55.80
- QTRX $5.60
- Resistance Level
- BETR $84.46
- QTRX $6.11
- Average True Range (ATR)
- BETR 8.04
- QTRX 0.32
- MACD
- BETR 1.00
- QTRX -0.00
- Stochastic Oscillator
- BETR 84.70
- QTRX 69.05
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.